Aminophy

Details About Generic Salt ::  Aminophy

Main Medicine Class:: Bronchodilator,xanthine derivative   

(am-in-AHF-ih-lin)
Phyllocontin, Truphylline,  Jaa-Aminophylline, Phyllocontin, Phyllocontin-350
Class: Bronchodilator/xanthine derivative

 

Drugs Class ::

 Action Relaxes bronchial smooth muscle and pulmonary blood vessels; stimulates central respiratory drive; increases diaphragmatic contractility.

Indications for Drugs ::

 Indications Prevention or treatment of reversible bronchospasm associated with asthma or COPD. Unlabeled use(s): Treatment of apnea and bradycardia of prematurity.

Drug Dose ::

 Route/Dosage

Dosage is calculated on basis of lean body weight.

ORAL/RECTAL

Dose is determined by percentage of theophylline content in aminophylline salt. Aminophylline is 79% theophylline.

Loading Dose

ADULTS & CHILDREN: PO/PR 5 mg/kg.

Maintenance Dose

HEALTHY NONSMOKERS: PO/PR 3 mg/kg q 8 hr. ELDERLY & PATIENTS WITH COR PULMONALE: 2 mg/kg q 8 hr. PATIENTS WITH CHF: 1 to 2 mg/kg q 12 hr. CHILDREN 9 TO 16 YR & YOUNG ADULT SMOKERS: 3 mg/kg q 6 hr. CHILDREN 1 TO 9 YR: 4 mg/kg q 6 hr.

PARENTERAL

Loading Dose

ADULTS &CHILDREN NOT RECEIVING THEOPHYLLINE: IV 6 mg/kg. ADULTS & CHILDREN RECEIVING THEOPHYLLINE: IV 0.6 to 3.1 mg/kg.

Maintenance Dose

HEALTHY NONSMOKERS: IV 0.5 to 0.7 mg/kg/hr. ELDERLY & PATIENTS WITH COR PULMONALE: IV 0.3 to 0.6 mg/kg/hr. PATIENTS WITH CHF: IV 0.1 to 0.5 mg/kg/hr. CHILDREN 9 TO 16 YR &YOUNG ADULT SMOKERS: IV 0.8 to 1 mg/kg/hr. CHILDREN 1 TO 9 YR: IV 1 to 1.2 mg/kg/hr. NEONATES-INFANTS < 6 MO: Not recommended. Weigh benefits against risks. INFANTS 26 TO 52 WK: Divide into q 6 hr dosing. INFANTS < 26 WK: Divide into q 8 hr dosing. INFANTS 6 TO 52 WK: = 24 hr dosage (mg). PREMATURE INFANTS > 4 Days Postnatal: IV 1.5 mg/kg q 12 hr. PREMATURE INFANTS < 24 DAYS POSTNATAL: IV 1 mg/kg q 12 hr.

Contraindication ::

 Contraindications Hypersensitivity to xanthines (eg, caffeine, theobromine) or ethylenediamine; peptic ulcer; seizure disorders not treated with medication. Aminophylline suppositories are contraindicated in presence of irritation or infection of rectum or lower colon.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children < 1 yr. Cardiac effects: Aminophylline may cause or worsen preexisting arrhythmias. GI effects: Aminophylline may cause or worsen preexisting ulcers or gastroesophageal reflux. Status asthmaticus: In this medical emergency parenteral medication and close monitoring in intensive care unit are recommended. Toxicity: Patients with liver impairment or cardiac failure and those > 55 yr are at greatest risk.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Palpitations; tachycardia; hypotension; arrhythmias. CNS: Irritability; headache; insomnia; muscle twitching; seizures. GI: Nausea; vomiting; anorexia, diarrhea; gastroesophageal reflux; epigastric pain. GU: Proteinuria; diuresis. RESP: Tachypnea; respiratory arrest. OTHER: Fever; flushing; hyperglycemia; inappropriate antidiuretic hormone secretion; sensitivity reactions (exfoliative dermatitis and urticaria).

Drug Mode of Action ::  

 Action Relaxes bronchial smooth muscle and pulmonary blood vessels; stimulates central respiratory drive; increases diaphragmatic contractility.

Drug Interactions ::

 Interactions

Allopurinol, nonselective betablockers, calcium channel blockers, cimetidine, oral contraceptives, corticosteroids, disulfiram, ephedrine, influenza virus vaccine, interferon, macrolide antibiotics, mexiletine, quinolone antibiotics, thyroid hormones: May increase aminophylline levels. Aminoglutethimide, barbiturates, hydantoins, ketoconazole, rifampin, smoking (tobacco and marijuana), sulfinpyrazone, sympathomimetics: May decrease aminophylline levels. Benzodiazepines, propofol: Aminophylline may antagonize sedative effects. Beta-agonists: Effects of both drugs may be antagonized. Carbamazepine, isoniazid, loop diuretics: May increase or decrease aminophylline levels. Food: Sustained-released medications are taken on empty stomach to avoid rapid drug release. Low-protein, high-carbohydrate diet may increase aminophylline levels. Charcoal-broiled foods or high-protein, low-carbohydrate diet may decrease aminophylline levels. Halothane: May cause catecholamine-induced arrhythmias. Ketamine: May result in seizures. Lithium: Aminophylline may reduce lithium levels. Nondepolarizing muscle relaxants: May antagonize neuromuscular blockade. INCOMPATIBILITIES: Do not mix with anileridine hydrochloride, ascorbic acid, chlorpromazine, codeine phosphate, dimenhydrinate, dobutamine hydroide, epinephrine, erythromycin gluceptate, hydralazine, insulin, levorphanol tartrate, meperidine, methadone, methicillin, morphine sulfate, norepinephrine bitartrate, oxytetracycline, penicillin G potassium, phenobarbital, phenytoin, prochlorperazine, promazine, promethazine, tetracycline, vancomycin, verapamil, vitamin B complex with vitamin C.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note sensitivity to xanthines (eg, caffeine, chocolate), peptic ulcer, seizure disorders, liver disease and current medication regimen.
  • Take vital signs before and after administration.
  • Note baseline ECG.
  • Assess lung sounds.
  • Measure and record I&O.
  • Position patient with head of bed elevated or place in position of comfort to reduce dyspnea.
  • Encourage fluid intake to liquify bronchial secretions.
  • Reduce patient’s intake of cola, coffee, and chocolate and use of cigarettes.
  • Report carbohydrate or protein restrictions in patient’s diet because theophylline dosage may need to be adjusted.
  • Monitor vital signs and cardiac status. If significant tachycardia or ventricular arrhythmias occur, withhold drug and report to physician.
  • In patients receiving theophylline products, monitor serum theophylline levels for toxicity. If levels are above therapeutic range (10 to 20 mcg/ml), report to physician.
  • In patients receiving erythromycin, beta-blockers (eg, atenolol, metoprolol, nadolol, propanolol), cimetidine or allopurinol, monitor for toxicity.
  • In patients receiving phenobarbital, rifampin, carbamazepine or lithium, monitor effectiveness of aminophylline; dosage may not be sufficient.

Drug Storage/Management ::

 Administration/Storage

  • Store at room temperature.

Tablets and Liquid

  • Give on empty stomach (½ to 1 hr before meals or 2 hr after meals).
  • Do not crush or chew extended-release forms; capsules may be opened and contents mixed with soft food. Scored tablets can be cut in half and then swallowed.

IV Infusion

  • Do not administer if solution is discolored or if crystals are present.
  • Rapid infusion may cause cardiac arrest.
  • Give undiluted drug at rate of 25 mg/min.
  • Dilute in Dextrose or saline solutions or Lactated Ringer’s. Administer diluted drug at rate of 25 mg/min (maximum). Once mixed, solution must be refrigerated and used within 24 hr.
  • Use of infusion pump is recommended for precise administration.
  • Do not mix aminophylline solution in syringe with other drugs. Separate IV infusion is recommended because of IV incompatibilities.

Suppositories

  • Do not use rectal route when irritation or infection is present.
  • May have special storage requirements.

IM Injection

  • IM route is usually not used because this method produces intense prolonged pain.

Drug Notes ::

 Patient/Family Education

  • Advise patient not to smoke. If patient changes smoking habits or stops smoking, dosage adjustment may be necessary.
  • Instruct patient to report the following symptoms to physician: Unusual worsening of symptoms, nausea, vomiting, excessive nervousness, insomnia, irregular heartbeat.
  • For patients taking theophylline, emphasize that serum theophylline levels should be tested every 6 to 12 mo.
  • Advise elderly patients to take safety precautions (eg, rise slowly, use handrails, request assistance in ambulation) if dizziness occurs.
  • Instruct patient to avoid foods or beverages containing caffeine and to limit intake of charcoal-broiled foods.
  • Advise patient not to take otc cough, cold, or breathing medications without consulting physician.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

Leave a comment

Your email address will not be published. Required fields are marked *

royalmpo Royalmpo Royalmpo royalmpo royalmpo royalmpo royalmpo https://malangtoday.id/ https://guyonanbola.com/ renunganhariankatolik.web.id royalmpo royalmpo royalmpo dewaslot168 ri188 https://hayzlett.com/c-suite-network/ kingslot jkt88 mpodewa https://going-natural.com/the-story-behind-the-mutilated-scalp-video/ royalmpo/ pisang88/ langkahcurang/ mpohoki/ mpocuan/ royalmpo/ mporoyal/ asiaslot/ rajaslot138/ royalmpo https://hayzlett.com/news/ rajaslot88/ Analisis Scatter Hitam MahjongWays RTP Terukur Kemenangan Puluhan Grid Fase Awal Mahjong Pola Perilaku Pemain Harian Prediksi Strategi Game Terbaik RTP Strategi Target Kemenangan Tekanan Meja Live Kasino Slot Digital Hiburan Ringan Slot Online Tanpa Target Mengelola Mood Pemain Slot https://going-natural.com/my-braid-locs/ https://going-natural.com/kellen-marcus/ narutoslot bangslot royalmpo royalmpo macanasia bosslot slotking gacorway
Strategi Analitik Platform Game Dalam Mengelola Variasi Pola Permainan Online Di Era Windows 12 Pendekatan Data Driven Dalam Memahami Ritme Sistem Permainan Digital Pada Ekosistem Android Modern Studi Dinamika Platform Gaming Melalui Distribusi Kombinasi Simbol Di Tengah Popularitas Xbox Game Pass Analisis Strategi Modern Dalam Mengelola Volatilitas Sistem Permainan Digital Saat Tren Nintendo Kembali Naik Framework Pengolahan Data Gaming Untuk Menjaga Stabilitas Pola Permainan Dalam Era Gemini AI Tools Teori Permainan Mahjong Ways Dalam Analisa Intensitas Sistem RTP Online Pada Perangkat Smartphone Modern Pendekatan Sistematis Dalam Menganalisis Pola Permainan Pada Ekosistem Gaming Setelah Discord Down Model Evaluasi Strategi Platform Game Melalui Observasi Pergerakan Algoritma Setelah Update iOS 26.3.1 Strategi Adaptif Dalam Mengelola Ritme Permainan Pada Platform Digital Dengan Dukungan Windows 12 Pendekatan Data Analitik Untuk Mengidentifikasi Pola Sistem Permainan Mobile Pada Samsung Galaxy S26 Ultra
Studi Adaptasi Strategi Permainan Mahjong Dalam Sistem Platform Digital Di Tengah Tren Nintendo Gaming Analisis Teknologi Gaming Platform Dalam Evolusi Sistem Permainan Berbasis RTP Di Era Gemini AI Pendekatan Sistematik Dalam Analisis Algoritma Permainan Mobile Saat Dark Mode Twitter Kembali Trending Studi Pola Mahjong Ways Dalam Perspektif Strategi Platform Game Pada Perangkat Smartphone Modern Analisis Perkembangan Algoritma Platform Gaming Dalam Sistem Permainan Pada Era Xbox Game Pass Pendekatan Manajemen Risiko Permainan Mobile Dalam Ekosistem Gaming Android Generasi Baru Strategi Pengamatan Sistem Permainan Dalam Lingkungan Platform Game Modern Saat Windows 12 Dibahas Evaluasi Sistem Gaming Platform Dalam Mengelola Variasi Pola Permainan Pada Perangkat Samsung Galaxy Framework Analitik Permainan Digital Dalam Mengelola Variasi Sistem Game Saat Re9 Update Dibahas Gamer Studi Dinamika Platform Game Melalui Pendekatan Analisis Data Di Era Apple Newsroom Digital Model Framework Strategi Permainan Digital Dalam Platform Gaming Berbasis Android Modern Strategi Pengelolaan Sistem Permainan Melalui Pendekatan Data Analitik Pada Infrastruktur Cloud Gaming Analisis Adaptasi Sistem Permainan Dalam Ekosistem Gaming Digital Saat Project Helix Menjadi Sorotan Pendekatan Modern Dalam Analisis Pola Permainan Berbasis Data Saat Gemini AI Digunakan Developer Evaluasi Dinamika Sistem Permainan Digital Melalui Observasi Data Pada Sistem iOS 26.3.1 Studi Struktur Sistem Game Dalam Perspektif Teknologi Gaming Di Tengah Tren Nintendo Global Pendekatan Framework Gaming Dalam Mengelola Pola Permainan Digital Di Tengah Popularitas Mario Day Analisis Perubahan Pola Mahjong Wins Dalam Ekosistem Gaming Modern Saat Re9 Update Diperbincangkan Model Analitik Pola Permainan Mahjong Dalam Sistem Platform Digital Modern Berbasis Android Studi Evolusi Teknologi Gaming Dalam Pengembangan Platform Permainan Pada Sistem Windows 12 Strategi Modern Membaca Sistem Permainan Digital Berbasis Algoritma Pada Infrastruktur Cloud Gaming Evaluasi Sistem Platform Game Dalam Dinamika Permainan Online Pada Era Smartphone Modern Pendekatan Data Platform Dalam Mengidentifikasi Pola Permainan Online Pada Infrastruktur TV App Strategi Pengolahan Data Gaming Dalam Mengelola Pola Permainan RTP Pada Infrastruktur Gaming Cloud Strategi Pengelolaan Pola Permainan Melalui Analisis Platform Digital Saat iPhone Generasi Baru Dirilis Pendekatan Analitik Sistem Game Dalam Mengelola Ritme Permainan Pada Era Xbox Game Pass Strategi Data Driven Dalam Menganalisis Pola Sistem Permainan Digital Pada Infrastruktur Cloud Studi Algoritma Permainan Mahjong Dalam Perspektif Platform Gaming Pada Ekosistem Android Analisis Sistem Permainan Digital Dalam Kerangka Strategi Platform Game Di Era Apple Ecosystem Dinamika Sistem Permainan Mahjong Digital Melalui Observasi Ritme Algoritma Pada Ekosistem Gaming Mobile Modern Pola Mahjong Ways 2 Hari Ini Strategi Malam Mahjong Wins 3 Kisah Sukses Andi Grid Mahjong & Starlight Saksi Mata: Mode Manual Mahjong Wins RTP Bertahap Pragmatic Spiral Pola Mahjong Ways Kurikulum Jackpot Respon Mahjong Wins 3 Lebih Cepat Akselerasi Free Spin Mahjong Wins3